Analyst firms · Robert W. Baird · ARGX

Robert W. Baird ARGX price target and rating history

argenx SE (ARGX) · Health Care

Robert W. Baird rates argenx SE (ARGX) Neutral with a $858 price target, as of its latest action on Dec 18, 2025. It has published 5 rating actions on ARGX since July 2022, including 2 upgrades and 3 downgrades. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185. Robert W. Baird's $858 is 28% below that.

Current rating
Neutral
Price target
$858
Median target, all firms
$1,185
Actions on ARGX
5

Robert W. Baird price target on ARGX

$858$659$4602023202420252026
Robert W. Baird price target on ARGX, each point a stated target, July 2022 to December 2025.

Every Robert W. Baird rating on ARGX

How other firms rate ARGX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$1,400Aug 26, 2026
Deutsche BankHoldAug 24, 2026
GuggenheimBuy$1,185Aug 4, 2026
Robert W. BairdNeutral$858Dec 18, 2025
Wolfe ResearchPeer PerformNov 24, 2025

Questions about Robert W. Baird and ARGX

What is Robert W. Baird's price target for ARGX?
Robert W. Baird's latest stated price target for argenx SE (ARGX) is $858, from its action on Dec 18, 2025.
What is Robert W. Baird's rating on ARGX?
Robert W. Baird rates ARGX Neutral, a neutral rating, as of Dec 18, 2025.
When did Robert W. Baird last change its view on ARGX?
On Dec 18, 2025, Robert W. Baird downgrades to Neutral from Outperform, price target $858.
How does Robert W. Baird's ARGX target compare with other analysts?
Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185. Robert W. Baird's $858 is 28% below that.

More ARGX rating histories

All Robert W. Baird ratingsARGX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.